投稿已於2023年10月06日(星期五)中午12點截止, 主辦單位將於2023年10月27日(星期五)前通知複審錄取者。 臺北榮民總醫院教學部於2023年11月17日(星期五)舉辦國際醫學教育研討會,本次研討會的主題為「The Impact of Generative AI and its Innovative Developments on Contemporary Medical Education (生成式AI及其創新發展對當代醫學教育的影響)」,我們邀請國內外專家學者們遠距或親臨現場演講與實務經驗分享,相信透過本活動,將對臨床教育提供嶄新思維,發展更加創新的內容。本研討會亦歡迎全國學術界及研究人員踴躍投稿發表相關主題經驗及研究結果。 本次研討會以實體方式進行,論文展示以實體海報或口頭呈現,評選方式分為兩階段:
初審-
評選內容:論文摘要word 評選結果:初審結果優良者將於會議當天口頭發表,其餘海報展示
複審-
評選內容:口頭發表或實體海報展示 評選結果:金、銀、銅、特優、優選、佳作
詳細規範如下: 一、徵稿內容範圍
AI對醫學教育影響與應用
系統化的評核操作/工具
創新的評估工具
CBME 創新評估糸統
全人/跨領域教育訓練的成果推廣
智慧醫療下全人/人文教育之創新研究
醫師工程師/科學家的人才培育
二、摘要投稿格式及規範
請使用Microsoft Office Word 2003或以上版本繕打(須能與Office 2003相容)。
語言:題目、作者姓名及服務單位為中英文並列,內文中英文皆可。
字型:Times New Roman(English)及標楷體(中文)。
大小:題目14級字、服務單位10級字並斜體、作者姓名及摘要內容12級字。
摘要內容:請依四段繕打,分別為背景(Background)、方法(Method)、結果(Results)、結論(Conclusion)、關鍵詞(Keywords)。以上皆不需加附註(References)或圖表(Figures and Tables)。
Tid1 in Head and Neck Cancer Tumorigenesis Tid1頭頸癌化過程之角色 Jeng-Fan Lo 羅正汎 Institute of Oral Biology, National Yang-Ming University School of Dentistry, and Department of Dentistry, Taipei Veterans General Hospital, Taipei, Taiwan, ROC 國立陽明大學牙醫學院口腔生物研究所及台北榮民總醫院口腔醫學部
Background: Tid1 is the human homologue of the Drosophila tumor suppressor Tid56, whose null mutation causes lethal tumorigenesis during the larval stage. The physiological function of Tid1 to mediate the tumorigenesis in various human cancer types has been reported. However, the molecular mechanism by which Tid1 involves in carcinogenesis in human head and neck squamous cell carcinoma (HNSCC) remains poorly understood. Herein, we investigated the clinical significance of Tid1 expression in HNSCC and its role in tumorigenesis.
Methods: To determine the expression patterns of Tid1 in HNSCC, the biopsies of 47 HNSCC cancerous tissues were examined by immunohistochemistry analysis. To evaluate the physiological function of Tid1 in human oral cancer cells, HNSCC cells overexpressing Tid1 were generated and the cell proliferation, cell motility, cell invasion, anchorage-independent growth of those cell, and in vivo tumorigenicity were examined. To verify the molecular mechanism of Tid1 involving in HNSCC, the EGFR molecular pathway of Tid1-expressing cells were examined.
Results: We showed that ectopically overexpression of Tid1 negatively regulated cell proliferation, anchorage-independent growth, cell motility, cell invasion, and tumorigenicity of oral cancer cells. Low Tid1 expression is associated with increased cancer recurrence and tumor status, but reduced patient survival in HNSCC patients. In addition, Tid1 attenuates EGFR activity and blocks the activation of AKT in HNSCC cells.
Conclusion: We demonstrate that Tid1 functions as a tumor suppressor in human HNSCC. Furthermore, molecular mechanism mediated by Tid1 might be a potential therapeutic target for HNSCC therapy.